²é¿´: 3113  |  »Ø¸´: 4

ÓÒ°¶

½ð³æ (ÕýʽдÊÖ)

[ÇóÖú] canertinib¿¨ÄÎÌæÄáÕâ¸ö¿¹Ö×ÁöÒ©ÎïÓÐûÓÐÉÏÊУ¿

canertinib¿¨ÄÎÌæÄáÕâ¸ö¿¹Ö×ÁöÒ©ÎïÓÐûÓÐÉÏÊУ¿Èç¹ûÓУ¬Ê²Ã´Ê±ºò£¿
»Ø¸´´ËÂ¥
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

hongju

¾èÖú¹ó±ö (СÓÐÃûÆø)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï ¡ï ¡ï
zhoudeli(½ð±Ò+1): ¶àл²ÎÓë¡£ 2011-12-25 17:47:35
mouse103: Ó¦ÖúÖ¸Êý+1 2012-05-20 05:30:39
ÓÒ°¶: ½ð±Ò+2, ¡ïÓаïÖú 2012-06-01 22:12:38
As no development has been reported for some time, this program is assumed to be discontinued.

Pfizer (formerly by Warner-Lambert), under license from the University of Auckland, was developing canertinib (CI-1033, PD-0183805), a water soluble, orally-available analog of PD-169414, an EGFR tyrosine kinase inhibitor, as a potential treatment for cancer [427113]. By January 2000, phase I trials were underway [353284], [352930]. In September 2001, the drug was reported to be in phase II trials [427113], [429152]; these trials were ongoing in June 2004 [542422].

» ±¾ÌûÒÑ»ñµÃµÄºì»¨£¨×îÐÂ10¶ä£©

2Â¥2011-12-25 16:13:43
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

ÓÒ°¶

½ð³æ (ÕýʽдÊÖ)

ËÍÏÊ»¨Ò»¶ä
ÒýÓûØÌû:
Â¥: Originally posted by hongju at 2011-12-25 16:13:43:
As no development has been reported for some time, this program is assumed to be discontinued.

Pfizer (formerly by Warner-Lambert), under license from the University of Auckland, was developing  ...

лл
3Â¥2011-12-25 17:27:13
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

ashuai078201

Í­³æ (СÓÐÃûÆø)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
mouse103: ½ð±Ò+1, лл²ÎÓë 2012-05-20 05:31:16
ÓÉÓÚûÓз¢Õ¹ÒѾ­±¨µÀÁËÒ»¶Îʱ¼ä£¬Õâ¸ö·½°¸ÊǼÙÉèÖÕÖ¹¡£
¸ø·­ÒëÏÂ
4Â¥2011-12-27 15:10:41
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

chem_gd

½ð³æ (³õÈëÎÄ̳)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
mouse103: ½ð±Ò+1, лл²ÎÓë 2012-05-20 05:31:33
ûÓÐÉÏÊС£»ÔÈð»¹ÓкóÐøµÄÀàËÆ·Ö×Ó£¬ÒÔ¼°Boehringer IngelheimÒ²ÓÐÀàËÆ·Ö×Ó£¬µ«ÊÇЧ¹û²»ÊǺܺá£
5Â¥2012-04-02 11:11:18
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ ÓÒ°¶ µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[»ù½ðÉêÇë] Ã÷ÌìÓ¦¸Ã¿É²éÁË£¡£¿ +5 chengyan1220 2026-08-23 5/250 2026-08-24 23:28 by ÎÒ4´ó°×²Ë
[»ù½ðÉêÇë] Èç¹û´Ë¿ÌÄãÕýÔÚΪ¹ú»ù¸Ðµ½½¹ÂÇ£¬²»·ÁÀ´ÌýÌýÕâÊס¶»ù½ðÖ®Íâ¡· +7 scalable 2026-08-24 7/350 2026-08-24 23:01 by anata1209
[»ù½ðÉêÇë] ûÓÐÈκÎÏûÏ¢-ÊDz»ÊǾÍÁ¹ÁË +7 ͼÀ²Í¼À² 2026-08-24 8/400 2026-08-24 22:00 by maomao_da
[ÂÛÎÄͶ¸å] ÊÛSCI-T0PÎÄÕ£¬ÎÒ:8O.5.5.1.O.54,¿ÆÄ¿ÆëÈ«,¿É+¼± +3 0XLacIJUOj8D 2026-08-24 3/150 2026-08-24 21:59 by BZKMTicpDhFj
[»ù½ðÉêÇë] ÈËÆø²»ÐÐÁË +10 fansofjerry 2026-08-21 10/500 2026-08-24 21:03 by zhanghaozhu
[»ù½ðÉêÇë] ÎÒÃæÉÏÍêµ°ÁË +9 ÇÒÌý»¢Ð¥ 2026-08-20 10/500 2026-08-24 20:08 by ¿àº®À´Ïã
[»ù½ðÉêÇë] filecode£¬4¸öjtjcÁË +14 ziyangfang 2026-08-19 17/850 2026-08-24 18:37 by ¹þ¹þ¸ò£¿
[»ù½ðÉêÇë] 2026¹ú×ÔÈ»º¯ÆÀ·Ñµ½ÕË +17 ÑòÑü°å 2026-08-21 19/950 2026-08-24 16:52 by iaeyuan
[»ù½ðÉêÇë] ½¨Òé»ù½ð·¢²¼Ìáǰ¸ø³öÃ÷È·µÄʱ¼äµã +13 kulium 2026-08-21 16/800 2026-08-24 16:27 by superceng
[»ù½ðÉêÇë] ¹À¼ÆÊÇÖÜËÄ +4 archvillain 2026-08-18 4/200 2026-08-24 13:53 by zzuzxg
[»ù½ðÉêÇë] ÅóÓÑȦ¿´µ½µÄ +7 wangzilk 2026-08-18 9/450 2026-08-24 10:50 by cmrandy
[»ù½ðÉêÇë] ÈÃÎÒÖÐÒ»¸öÃæÉϰɣ¡ +13 ´óƼ1987 2026-08-20 16/800 2026-08-24 10:23 by ̫ɵÁË
[»ù½ðÉêÇë] ¿ÆÑй¶ùÌ«ÄÑÁË +18 ÎÒ4´ó°×²Ë 2026-08-20 19/950 2026-08-24 09:47 by ¿­¶÷¹ãÊ¢´ß»¯·ÖÎ
[»ù½ðÉêÇë] ʲôʱºò¿ª½±£¿ +10 CrisMessi 2026-08-18 11/550 2026-08-24 06:50 by ¿ªÐĵÄСʨ×Ó
[½Ìʦ֮¼Ò] Ìø²ÛºóÔÚÑÐÏîÄ¿Ôõô°ì£¿ +5 ¼òµ¥»¯xn 2026-08-22 10/500 2026-08-23 12:38 by ¼òµ¥»¯xn
[»ù½ðÉêÇë] ½ñÌì·Å°ñÂ𣿠+15 ²¼²¼ºÍÒ»¶þ 2026-08-19 16/800 2026-08-23 09:55 by ÕÅ´ºÉú
[»ù½ðÉêÇë] Ö»ÓÐÿÄêÕâÖÖʱºòÀ´¹ä¹äСľ³æ +24 yaoyewhu2008 2026-08-20 26/1300 2026-08-22 17:43 by kammury
[»ù½ðÉêÇë] Ó¦¸ÃÊÇÏÂÖÜÈý26ÈÕ¹«²¼Á˰ɣ¿ +4 ¹þ¹þ¸ò£¿ 2026-08-21 4/200 2026-08-21 10:58 by Vivilian
[»ù½ðÉêÇë] ÖØÒªÏûÏ¢£¬ÖÐÎçϵͳÔÚά»¤ +11 yuleib84 2026-08-18 12/600 2026-08-20 11:09 by xskun
[»ù½ðÉêÇë] Ã÷Ìì·Å°ñ£¿ +5 Shxjjxjkx 2026-08-18 5/250 2026-08-18 18:14 by -´ó´ó´ó´ó´ó-
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û